The Government has begun negotiations to secure a “variant vaccine” adapted to tackle the variant first identified in South Africa, Health Secretary Matt Hancock said.
The B.1.351 variant, also known as the Beta variant, has caused concern among health officials after a study suggested that the traditional Oxford/AstraZeneca jab was less effective when tested against it.
In a speech delivered at the Jenner Institute in Oxford, Mr Hancock said: “There is yet more to do, the work isn’t over yet – we’re still procuring all the time, and planning what we need to keep this country safe, including new vaccines specifically targeted at variants of concern.
“I can tell you today that we’ve started commercial negotiations with AstraZeneca to secure a variant vaccine – future supplies of the Oxford/AstraZeneca vaccine that have been adapted to tackle the B.1.351 variant first identified in South Africa.
“Once again, we’re leading the way and backing projects with potential, so we can keep our vaccination programme one step ahead of the virus and protect the progress that we’ve all made.”
READ MORE: Single-shot Johnson & Johnson Covid vaccine approved for use in UK
AstraZeneca has said that any future version of its vaccine would need to be approved for use by medicines regulators.
In a statement, the company said: “AstraZeneca is in discussions with the UK Government regarding future versions of our Covid-19 vaccine to specifically address variants.
“We will share more details in due course.
“Any future version of the vaccine would need to be approved for use by the medicines regulator.”
Because of concerns about the variant, Test and Trace experts have jumped on any case found in the UK, and launched immediate rapid Covid-19 lab tests for people in areas where clusters have been identified.
Surge testing and so-called enhanced contact tracing has been deployed in a number of areas including parts of London.
READ MORE: New vaccine research centre ‘a real vote of confidence’ in the UK - Matt Hancock
To May 19, 904 cases have been identified in the UK – a rise of 41 from the previous week, according to Public Health England data.
Pfizer has previously said that there is currently no evidence that its jab needs updating against current known variants.
Why are you making commenting on The Herald only available to subscribers?
It should have been a safe space for informed debate, somewhere for readers to discuss issues around the biggest stories of the day, but all too often the below the line comments on most websites have become bogged down by off-topic discussions and abuse.
heraldscotland.com is tackling this problem by allowing only subscribers to comment.
We are doing this to improve the experience for our loyal readers and we believe it will reduce the ability of trolls and troublemakers, who occasionally find their way onto our site, to abuse our journalists and readers. We also hope it will help the comments section fulfil its promise as a part of Scotland's conversation with itself.
We are lucky at The Herald. We are read by an informed, educated readership who can add their knowledge and insights to our stories.
That is invaluable.
We are making the subscriber-only change to support our valued readers, who tell us they don't want the site cluttered up with irrelevant comments, untruths and abuse.
In the past, the journalist’s job was to collect and distribute information to the audience. Technology means that readers can shape a discussion. We look forward to hearing from you on heraldscotland.com
Comments & Moderation
Readers’ comments: You are personally liable for the content of any comments you upload to this website, so please act responsibly. We do not pre-moderate or monitor readers’ comments appearing on our websites, but we do post-moderate in response to complaints we receive or otherwise when a potential problem comes to our attention. You can make a complaint by using the ‘report this post’ link . We may then apply our discretion under the user terms to amend or delete comments.
Post moderation is undertaken full-time 9am-6pm on weekdays, and on a part-time basis outwith those hours.
Read the rules here